Adapting the FACETS Program to Sickle Cell Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorVersailles Hospital
About this trial
Adaptation of a fatigue management program combining the principles of cognitive-behavioral therapy and energy conservation strategies (FACETS program) for a population of adult patients with sickle cell disease (Drépa-FACETS program).
Eligibility criteria
Qualifiers
Participant having freely given his oral agreement.
Participant with a major sickle cell syndrome, regardless of genotype (e.g. SS, SC, Sbeta).
Participant with a sufficient command of spoken and written French to take the assessments, complete the questionnaires, follow the program sessions and carry out the home exercises.
Disqualifiers
Participant with one or more severe psychiatric pathologies (e.g. severe depression, psychosis) that could interfere with the conduct of the study, in particular the primary and secondary endpoints.
Participants with another chronic pathology causing fatigue.
Participants in vaso-occlusive crisis (VOC) or hospitalization.
Participant under legal protection (guardianship, curatorship, safeguard of justice, deprived of liberty).
Trial design
Treatments tested in this trial
- Drépa-FACETS Program
Treatment groups
24 Participants
are divided into 1 treatment groupSponsors and collaborators
Versailles Hospital
Lead sponsor
University Hospital, Grenoble
Collaborator
University Grenoble Alps
Collaborator
Paris Nanterre University
Collaborator
Source ClinicalTrials.gov